BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 28553792)

  • 1. Adherence to Guidelines for Screening and Medication Use: Mortality and Onset of Major Macrovascular Complications in Elderly Persons With Diabetes Mellitus.
    Yashkin AP; Sloan F
    J Aging Health; 2018 Apr; 30(4):503-520. PubMed ID: 28553792
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Adherence to diabetes guidelines for screening, physical activity and medication and onset of complications and death.
    Chen Y; Sloan FA; Yashkin AP
    J Diabetes Complications; 2015; 29(8):1228-33. PubMed ID: 26316423
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mortality and Macrovascular Risk in Elderly With Hypertension and Diabetes: Effect of Intensive Drug Therapy.
    Yashkin AP; Kravchenko J; Yashin AI; Sloan F
    Am J Hypertens; 2018 Jan; 31(2):220-227. PubMed ID: 28985276
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Multiple medication adherence and its effect on clinical outcomes among patients with comorbid type 2 diabetes and hypertension.
    An J; Nichol MB
    Med Care; 2013 Oct; 51(10):879-87. PubMed ID: 23929398
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Risk of acute myocardial infarction, stroke, heart failure, and death in elderly Medicare patients treated with rosiglitazone or pioglitazone.
    Graham DJ; Ouellet-Hellstrom R; MaCurdy TE; Ali F; Sholley C; Worrall C; Kelman JA
    JAMA; 2010 Jul; 304(4):411-8. PubMed ID: 20584880
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Longitudinal incidence and prevalence of adverse outcomes of diabetes mellitus in elderly patients.
    Bethel MA; Sloan FA; Belsky D; Feinglos MN
    Arch Intern Med; 2007 May; 167(9):921-7. PubMed ID: 17502533
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Newly diagnosed and previously known diabetes mellitus and 1-year outcomes of acute myocardial infarction: the VALsartan In Acute myocardial iNfarcTion (VALIANT) trial.
    Aguilar D; Solomon SD; Køber L; Rouleau JL; Skali H; McMurray JJ; Francis GS; Henis M; O'Connor CM; Diaz R; Belenkov YN; Varshavsky S; Leimberger JD; Velazquez EJ; Califf RM; Pfeffer MA
    Circulation; 2004 Sep; 110(12):1572-8. PubMed ID: 15364810
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Thiazolidinediones and cardiovascular outcomes in older patients with diabetes.
    Lipscombe LL; Gomes T; Lévesque LE; Hux JE; Juurlink DN; Alter DA
    JAMA; 2007 Dec; 298(22):2634-43. PubMed ID: 18073359
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of Outcomes and Prognosis of Patients With Versus Without Newly Diagnosed Diabetes Mellitus After Primary Percutaneous Coronary Intervention for ST-Elevation Myocardial Infarction (the HORIZONS-AMI Study).
    Ertelt K; Brener SJ; Mehran R; Ben-Yehuda O; McAndrew T; Stone GW
    Am J Cardiol; 2017 Jun; 119(12):1917-1923. PubMed ID: 28427734
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Causes of the change in the rates of mortality and severe complications of diabetes mellitus: 1992-2012.
    Yashkin AP; Picone G; Sloan F
    Med Care; 2015 Mar; 53(3):268-75. PubMed ID: 25675404
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Elevated risk of death and major cardiovascular events in subjects with newly diagnosed diabetes: findings from an administrative database.
    Monesi L; Tettamanti M; Cortesi L; Baviera M; Marzona I; Avanzini F; Monesi G; Nobili A; Riva E; Fortino I; Bortolotti A; Fontana G; Merlino L; Trevisan R; Roncaglioni MC
    Nutr Metab Cardiovasc Dis; 2014 Mar; 24(3):263-70. PubMed ID: 24418374
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Variation in antidiabetic medication intensity among Medicare beneficiaries with diabetes mellitus.
    Stuart B; Shaffer TJ; Simoni-Wastila LJ; Zuckerman IH; Quinn CC
    Am J Geriatr Pharmacother; 2007 Sep; 5(3):195-208. PubMed ID: 17996659
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Secondary prevention of macrovascular events in patients with type 2 diabetes in the PROactive Study (PROspective pioglitAzone Clinical Trial In macroVascular Events): a randomised controlled trial.
    Dormandy JA; Charbonnel B; Eckland DJ; Erdmann E; Massi-Benedetti M; Moules IK; Skene AM; Tan MH; Lefèbvre PJ; Murray GD; Standl E; Wilcox RG; Wilhelmsen L; Betteridge J; Birkeland K; Golay A; Heine RJ; Korányi L; Laakso M; Mokán M; Norkus A; Pirags V; Podar T; Scheen A; Scherbaum W; Schernthaner G; Schmitz O; Skrha J; Smith U; Taton J;
    Lancet; 2005 Oct; 366(9493):1279-89. PubMed ID: 16214598
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of diabetes mellitus and metformin use on oncologic outcomes of patients treated with radical cystectomy for urothelial carcinoma.
    Rieken M; Xylinas E; Kluth L; Crivelli JJ; Chrystal J; Faison T; Lotan Y; Karakiewicz PI; Sun M; Fajkovic H; Babjuk M; Bachmann A; Scherr DS; Shariat SF
    Urol Oncol; 2014 Jan; 32(1):49.e7-14. PubMed ID: 24140245
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association of obesity and long-term mortality in patients with acute myocardial infarction with and without diabetes mellitus: results from the MONICA/KORA myocardial infarction registry.
    Colombo MG; Meisinger C; Amann U; Heier M; von Scheidt W; Kuch B; Peters A; Kirchberger I
    Cardiovasc Diabetol; 2015 Feb; 14():24. PubMed ID: 25885918
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Increased risk of gastrointestinal malignancy in patients with diabetes mellitus and correlations with anti-diabetes drugs: a nationwide population-based study in Taiwan.
    Chiu CC; Huang CC; Chen YC; Chen TJ; Liang Y; Lin SJ; Chen JW; Leu HB; Chan WL
    Intern Med; 2013; 52(9):939-46. PubMed ID: 23648711
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impact of Insurance Status on Outcomes and Use of Rehabilitation Services in Acute Ischemic Stroke: Findings From Get With The Guidelines-Stroke.
    Medford-Davis LN; Fonarow GC; Bhatt DL; Xu H; Smith EE; Suter R; Peterson ED; Xian Y; Matsouaka RA; Schwamm LH
    J Am Heart Assoc; 2016 Nov; 5(11):. PubMed ID: 27930356
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cardiovascular Outcomes of Dipeptidyl Peptidase-4 Inhibitors in Elderly Patients With Type 2 Diabetes: A Nationwide Study.
    Shih CJ; Chen HT; Kuo SC; Ou SM; Chen YT
    J Am Med Dir Assoc; 2016 Jan; 17(1):59-64. PubMed ID: 26612484
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The growing burden of diabetes mellitus in the US elderly population.
    Sloan FA; Bethel MA; Ruiz D; Shea AM; Feinglos MN
    Arch Intern Med; 2008 Jan; 168(2):192-9; discussion 199. PubMed ID: 18227367
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of cardiovascular outcomes in elderly patients with diabetes who initiated rosiglitazone vs pioglitazone therapy.
    Winkelmayer WC; Setoguchi S; Levin R; Solomon DH
    Arch Intern Med; 2008 Nov; 168(21):2368-75. PubMed ID: 19029503
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.